Issue: December 2016
October 24, 2016
2 min read
Save

Consider clear-lens extraction first-line treatment for PACG

Issue: December 2016
You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Clear-lens extraction improved overall health status, visual impairment and disability, and glaucoma-specific disability in primary angle closure and primary angle-closure glaucoma, according to researchers in The Lancet.

Perspective from Carl H. Jacobsen, OD, FAAO

Of 419 patients enrolled from 30 hospital eye services in five countries, 155 had primary angle closure and 263 had primary angle-closure glaucoma (PACG). A total of 208 were assigned to clear-lens extraction and 211 to standard care.

European Quality of Life-5 Dimensions scores and intraocular pressure at 36 months significantly favored the clear-lens extraction group, according to the study.

National Eye Institute Visual Function Questionnaire-25 and Glaucoma Utility Index scores at 36 months were significantly higher in the clear-lens extraction group than in the standard care group.

Significantly fewer patients in the clear-lens extraction group needed treatment to control IOP, and fewer needed glaucoma medications than patients who received standard care, researchers found.

At 3 years, the mean IOP was about 1 mm Hg lower in the clear-lens extraction group.

The clear-lens extraction group showed higher total quality-adjusted life-years, and the procedure was more cost-effective than laser peripheral iridotomy.

“...the consistent superiority of clear-lens extractions in terms of patient-reported and clinical benefits and the absence of serious safety issues provide strong support for considering this approach as the first-line treatment for individuals with primary angle-closure disease,” researchers wrote. – by Abigail Sutton

Disclosure: The researchers reported no relevant financial disclosures.